Rheumatoid arthritis synovial fluid fibroblasts express TRAIL‐R2 (DR5) that is functionally active
Open Access
- 9 September 2004
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (9) , 2786-2793
Abstract
Objective: To examine fibroblasts grown from the synovial fluid of rheumatoid arthritis (RA) patients for TRAIL‐R2 expression, and for susceptibility to apoptosis induced by an agonistic anti–TRAIL‐R2 monoclonal antibody (mAb).Methods: The expression of TRAIL‐R2 (DR5) was determined by flow cytometry on fibroblasts grown from the synovial fluid of patients with RA, osteoarthritis (OA), seronegative arthritis, and unclassified monarthritis or oligoarthritis, and on fibroblasts from the synovial membrane of RA and OA patients. Susceptibility to apoptosis mediated by an agonistic anti–TRAIL‐R2 mAb was determined by alamar blue bioassay, fluorescence microscopy (annexin V/propidium iodide staining), and caspase activation.Results: Fibroblasts grew from 35 of 50 RA synovial fluid samples, of which 26 were DR5+ (mean [±SD] fluorescence intensity [MFI] 18.74 ± 2.5). Fibroblasts also grew from 15 of 30 seronegative arthritis synovial fluid samples, 28 of 40 OA synovial fluid samples, and 8 of 20 unclassified monarthritis or oligoarthritis synovial fluid samples; all of these were DR5− (MFI 0.32 ± 0.02). All 10 of the fibroblast lines from joint replacement surgery or synovectomy specimens of RA patients were DR5+ (MFI 20.3 ± 3.2). All fibroblast lines from the synovium of 10 OA patients were DR5−, as were fibroblasts from the skin of 5 healthy subjects. DR5+ fibroblast cultures underwent apoptosis when treated in vitro with an agonistic anti‐DR5 antibody.Conclusion: Fibroblasts grown from the synovial fluid and synovial membrane of RA patients express TRAIL‐R2 that is functionally active. An agonistic anti–TRAIL‐R2 antibody that does not induce hepatocyte toxicity may be an alternative strategy for treatment of RA.Keywords
Funding Information
- Ministerio de Ciencia y Tecnología (SAF 2003-01670)
- Ministerio de Ciencia y Tecnología Programa Ramón y Cajal
This publication has 19 references indexed in Scilit:
- Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritisArthritis & Rheumatism, 2004
- Rheumatoid arthritis synovial fluid macrophages express decreased tumor necrosis factor–related apoptosis‐inducing ligand R2 and increased decoy receptor tumor necrosis factor–related apoptosis‐inducing ligand R3Arthritis & Rheumatism, 2003
- Functional characterization of adherent synovial fluid cells in rheumatoid arthritis: Destructive potential in vitro and in vivoArthritis & Rheumatism, 2003
- Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL−/− miceNature Immunology, 2003
- Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.Journal of Clinical Investigation, 1997
- Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis.Journal of Experimental Medicine, 1996
- Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.Annals of the Rheumatic Diseases, 1990
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the kneeArthritis & Rheumatism, 1986
- Cytology of rheumatoid synovial cells in culture. I. Composition and sequence of cell populations in cultures of rheumatoid synovial fluid.Annals of the Rheumatic Diseases, 1974